leisure time -WSS

leisure time

author：comprehensive 2025-09-03 03:32:45 - browse：5833

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Surprise medical billing ban raises prices elsewhere

WSS

As AI regulations shape up, health tech startups beg for clarity

Having children helps parents live longer, especially after age 80

AMAs digital advisors table RPM coding reform proposal, again

Ukraine seeks to reclaim its role as a hub for clinical trials

STAT Boddities: What happens to the brain when we get scared?

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Jerome Adams on the need for new antivirals for Covid

Resistance to opioid

As demand for Covid shots wanes, Moderna seeks its next success

Too many hospitalized Covid

Guidelines to prevent youth baseball injuries need more muscle

Tome Biosciences co

Medical leaders decry Supreme Court decision on affirmative action

Study gives hint on South Asians’ higher risk of cardiovascular disease

hotspot

Having children helps parents live longer, especially after age 80

Obamacare plans could cover weight loss drugs

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Latigo launches with $135 million for Vertex

Long Covid research funding gets a major boost from NIH

Congress may force more Covid

hotspot

entertainment

focus

focus